REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ligachem Biosciences Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Nanotechnology
Full name: Ligachem Biosciences Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

LegoChem Biosciences, Inc is a bio enterprise specializing in developing next-generation technologies for new medicine development, utilizing unique technology and knowledge to overcome technological limits.

Headquarters
8-26 Munpyeongseo-Ro, Daedeok-Gu, Gwangyeok-Si
Daejeon; Daejeon;

Contact Details: Purchase the Ligachem Biosciences Inc. report to view the information.

Website: http://www.legochembio.com

Basic Information
Total Employees:
Purchase the Ligachem Biosciences Inc. report to view the information.
Outstanding Shares:
Purchase the Ligachem Biosciences Inc. report to view the information.
Registered Capital:
Purchase the Ligachem Biosciences Inc. report to view the information.
Financial Auditors:
Purchase the Ligachem Biosciences Inc. report to view the information.
Incorporation Date:
May 02, 2006
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
17.24%
Purchase this report to view the information.
6.06%
Purchase this report to view the information.
3.03%
Purchase this report to view the information.
2.86%
Purchase this report to view the information.
0.21%
Subsidiaries
Geom Therapeutics
10.04%
(주)인투셀
4.36%
브릿지바이오
2.33%
Company Performance
Financial values in the chart are available after Ligachem Biosciences Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
36.18%▲
Total operating revenue
35.97%▲
Operating Profit/Loss (EBIT)
-403.93%▼
EBITDA
-927.95%▼
Net Profit/Loss for the Period
N/A
Total Assets
-3.81%▼
Total Equity
-11.65%▼
Operating Profit Margin (ROS)
-18.93%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
-1.49%▼
Quick Ratio
2.15%▲
Cash Ratio
0.45%▲

Similar companies

Cj Cheiljedang Corporation
 
Kt&G Corporation
Amore Pacific Group
 
Samsung Biologics Co., Ltd.
Green Cross Holdings Corporation
 
Yuhan Corporation
Bukwang Pharmaceutical Co.,Ltd.
 
Hwail Pharm. Co.,Ltd.
Kolon Life Science Inc.
 
Rpbio Inc.
Green Cross Well Being Corporation
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo